{
  "schemaVersion": 1,
  "id": "research-385",
  "slug": "385-how-a-pragmatic-trial-studies-tirzepatide-in-everyday-care",
  "title": "How a pragmatic trial studies tirzepatide in everyday care",
  "catalogLabel": "TIRZ GLP-2",
  "productCollection": "https://heritagebiolabs.com/research-library/products/tirz-glp-2",
  "productHandles": [
    "tirz-glp-2-692"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/tirz-glp-2-692"
  ],
  "readingFocus": "Mechanisms & biology",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 273,
  "sourceYears": [
    2022,
    2026
  ],
  "paragraphs": [
    "Peptides are short amino-acid chains whose links are peptide bonds. Some can mimic signals that help the body regulate nutrients and appetite. Tirzepatide is a GIP and GLP-1 receptor agonist peptide. The “GLP-2” in this catalog label does not identify a receptor it activates. In 2026, the SURMOUNT-REAL UK investigators published a plan to assess how offering tirzepatide would affect outcomes in a routine primary care setting. [1, 2]",
    "The planned trial will randomize approximately 3,000 adults in Greater Manchester. Eligible participants have class I obesity and do not have diabetes. They will be assigned to standard care or to the offer of tirzepatide alongside standard care. Participants and care providers can know which group was assigned. The researchers will use electronic health records alongside other information to follow participants over five years. [1]",
    "The main outcome is percentage change in body weight at two years. The investigators also plan to examine time to onset of type 2 diabetes by five years and measures such as healthcare use, quality of life and work-related outcomes. A trial that includes routine care can help researchers understand what happens when a treatment is offered in the system where people actually receive care. The comparison depends on the local setting and its definition of standard care. [1]",
    "The 2026 paper describes a protocol. The planned number of participants and length of follow-up describe what the study intends to do. They are not results about weight, diabetes or healthcare use. The design identifies outcomes that differ from some of the shorter, more tightly controlled trials and makes those outcomes available for later comparison when findings are reported. [1]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Martin K. Rutter et al. SURMOUNT-REAL UK: A Pragmatic Randomized Clinical Trial to Assess the Effectiveness of Tirzepatide in Adults With Obesity. Obesity (publication 2026-06-15).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/42297568/"
    },
    {
      "number": 2,
      "citation": "Bingfa Sun et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proceedings of the National Academy of Sciences (publication 2022-03-25).",
      "url": "https://pubmed.ncbi.nlm.nih.gov/35333651/"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/385-how-a-pragmatic-trial-studies-tirzepatide-in-everyday-care",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/385-how-a-pragmatic-trial-studies-tirzepatide-in-everyday-care.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/385-how-a-pragmatic-trial-studies-tirzepatide-in-everyday-care.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 077 - Thymosin Alpha-1 and TIRZ GLP-2.docx",
    "sourceArticleNumber": 385,
    "contentSha256": "e7de79faa9a03dd97625292ff6ba0dc76385fdaae3fc587a7502961cd0487650",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
